Type 2 diabetes mellitus and biomarkers of neurodegeneration
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received March 26, 2015
- Accepted in final form June 3, 2015
- First Published September 2, 2015.
Article Versions
- Previous version (September 2, 2015 - 13:00).
- You are viewing the most recent version of this article.
Author Disclosures
- Chris Moran, MBBCh,
- Richard Beare, PhD,
- Thanh G. Phan, PhD,
- David G. Bruce, MD,
- Michele L. Callisaya, PhD and
- Velandai Srikanth, PhD
- On behalf of the Alzheimer's Disease Neuroimaging Initiative (ADNI)
- Chris Moran, MBBCh,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Alzheimer?s Australia Dementia Research Foundation Scholarship.
NONE
NONE
NONE
NONE
NONE
NONE
- Richard Beare, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Thanh G. Phan, PhD,
Advisory Board for Genzyme
NONE
NONE
Associate Editor, Frontiers in Neurology (Stroke subsection)
NONE
NONE
NONE
Advisory Board for Genzyme
Genzyme; Bayer; Boehringer Ingelheim; Pfizer, BMS
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- David G. Bruce, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Michele L. Callisaya, PhD and
Royal Hobart Hospital Research Foundation Scientific Advisory Committee
NONE
NONE
NONE
NONE
NONE
NONE
Pfizer pharmaceuticals for contributing to a pain education resource for General Practitioners
NONE
NONE
NONE
NONE
NHRMC Early Career Fellowship 2012-15 1034483
NONE
Alzheimer Australia Dementia Research Foundation Royal Hobart Hospital Research Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- Velandai Srikanth, PhD
NONE
NONE
NONE
(1) International Journal of Stroke, 2013, (2) Frontiers of Neurology, 2014
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
National Health and Medical Research Council of Australia, grants 403000, 491109, 606544' years 2006 till present.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Stroke and Ageing Research Group (C.M., T.G.P., V.S.), Vascular Brain Ageing Division, Department of Medicine, School of Clinical Sciences, Monash University, Melbourne; Neurosciences (C.M., T.G.P., V.S.), Monash Medical Centre, Monash Health, Melbourne; Caulfield General Medical Centre (C.M.), Alfred Health, Melbourne; Developmental Imaging (R.B.), Murdoch Children's Research Institute, Melbourne; School of Medicine and Pharmacology (D.G.B.), Fremantle Hospital, University of Western Australia; and Menzies Research Institute Tasmania (M.L.C., V.S.), University of Tasmania, Hobart, Australia.
- Correspondence to Dr. Srikanth: velandai.srikanth{at}monash.edu
Article usage
Cited By...
Disputes & Debates: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.